p53 and E2F-1 cooperate to mediate apoptosis.
AUTOR(ES)
Wu, X
RESUMO
The tumor-suppressor protein p53 appears to function at the G1 phase of the cell cycle as a checkpoint in response to DNA damage. Mutations in the p53 gene lead to an increased rate of genomic instability and tumorigenesis. The E2F-1 transcription factor is a protein partner of the retinoblastoma-susceptibility gene product, RB. E2F-1 appears to function as a positive regulator or signal for entry into S phase. To explore possible interactions of p53 and E2F-1 in the cell cycle, a human E2F-1 expression plasmid was introduced into a murine cell line containing a temperature-sensitive p53 allele which produces a p53 protein in the wild-type conformation at 32 degrees C and the mutant form at 37.5 degrees C. Coexpression of the wild-type p53 protein and E2F-1 in these cells resulted in a rapid loss of cell viability through a process of apoptosis. Thus, the cell cycle utilizes an interacting or communicative pathway between RB-E2F-1 and p53.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=43628Documentos Relacionados
- Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
- E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis.
- E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.
- Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis.
- E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and Apoptosis